Institutional Ownership Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO). We have compiled data on the 290 institutions that hold shares in the stock, with a total of 170 Million shares, which have been reported (via 13F filing form) to have a value of $4.73 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
1,279,303
shares
|
$35.5 Million
0.01% of portfolio
|
Q3 2024
Added 13.31%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
1,216,116
shares
|
$33.8 Million
0.0% of portfolio
|
Q3 2024
Added 590.66%
|
|
|
Emerald Advisers, LLC
|
Oct 29, 2024 Q3 2024 |
1,103,508
shares
|
$30.6 Million
1.17% of portfolio
|
Q3 2024
Added 65.61%
|
|
|
Prosight Management, LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
1,086,810
shares
|
$30.2 Million
7.43% of portfolio
|
Q3 2024
Added 35.85%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
1,086,793
shares
|
$30.2 Million
0.01% of portfolio
|
Q3 2024
Reduced 0.51%
|
|
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
Nov 14, 2024 Q3 2024 |
1,023,950
shares
|
$28.4 Million
0.6% of portfolio
|
Q3 2024
Reduced 26.37%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
949,749
shares
|
$26.4 Million
0.22% of portfolio
|
Q3 2024
Added 0.02%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
926,846
shares
|
$25.7 Million
0.01% of portfolio
|
Q3 2024
Reduced 15.49%
|
|
|
Primecap Management CO
Pasadena, CA |
Nov 08, 2024 Q3 2024 |
906,724
shares
|
$25.2 Million
0.02% of portfolio
|
Q3 2024
Reduced 2.18%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
857,457
shares
|
$23.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 21.24%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Nov 14, 2024 Q3 2024 |
842,644
shares
|
$23.4 Million
3.93% of portfolio
|
Q3 2024
Reduced 7.41%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
833,236
shares
|
$23.1 Million
0.03% of portfolio
|
Q3 2024
Added 2601.01%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
810,465
shares
|
$22.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.74%
|
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 29, 2024 Q3 2024 |
751,355
shares
|
$20.9 Million
1.08% of portfolio
|
Q3 2024
Added 50.8%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2024 Q3 2024 |
748,819
shares
|
$20.8 Million
0.09% of portfolio
|
Q3 2024
Added 2.86%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Nov 12, 2024 Q3 2024 |
737,367
shares
|
$20.5 Million
0.01% of portfolio
|
Q3 2024
Added 23.25%
|
|
|
Eventide Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
716,927
shares
|
$19.9 Million
0.32% of portfolio
|
Q3 2023
Reduced 23.83%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
715,157
shares
|
$19.9 Million
0.0% of portfolio
|
Q3 2024
Added 5.69%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
660,265
shares
|
$18.3 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.49%
|
|
|
Octagon Capital Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
552,000
shares
|
$15.3 Million
3.39% of portfolio
|
Q3 2024
Reduced 20.0%
|
|
|
683 Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
550,000
shares
|
$15.3 Million
1.27% of portfolio
|
Q3 2024
Added 175.0%
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
545,008
shares
|
$15.1 Million
0.0% of portfolio
|
Q3 2024
Added 31.88%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
524,361
shares
|
$14.6 Million
0.0% of portfolio
|
Q3 2024
Reduced 26.89%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
518,806
shares
|
$14.4 Million
0.02% of portfolio
|
Q3 2024
Added 150.29%
|
|
|
Frontier Capital Management CO LLC
|
Nov 14, 2024 Q3 2024 |
503,162
shares
|
$14 Million
0.13% of portfolio
|
Q3 2024
Added 239.13%
|